Identification of two forms of myosin light chain kinase in turkey gizzard  by Walsh, Michael P. et al.
Volume 1.53, number 1 FEBS LETTERS March 1983 
Identification of two forms of myosin light chain kinase in 
turkey gizzard 
Michael P. Walsh, Susan Hinkins+, Michio Muguruma+ and David J. Hartshorne+ 
Department of Medical Biochemistry, University of Calgary, Calgary, Alberta T2N IN4, Canada and +Muscle 
Biology Group, Departments of Biochemistry and Nutrition and Food Science, University of Arizona, Tucson, AZ 
85721, USA 
Received 15 December 1982 
Two forms of myosin light chain kinase from turkey gizzard are separable by ion-exchange chromato- 
graphy. One is the well-characterized 130 000 M, enzyme. Purification of the second form by affinity 
chromatography on calmodulin-Sepharose showed it to consist of two polypeptide chains of M, 136 000 
and 141 000. This form of the enzyme required Ca*+ and calmodulin for activity, was specific for the M, 
20 Ooo light chain of myosin, and appeared to phosphorylate the same site on the light chain as the M, 
130 000 enzyme. The low-M, gizzard kinase may be a proteolytic fragment of a higher-Mr species or these 
may represent different isoenzymes. 
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1. INTRODUCTION 
Myosin light chain kinase catalyzes transfer of 
the terminal phosphate of ATP to a specific serine 
residue of the M, 20000 light chain of smooth mus- 
cle myosin. This enzyme is believed to mediate the 
Ca2+-induced contraction of smooth muscle, and 
possibly non-muscle motile systems, through its 
absolute dependence on calmodulin [l-3]. Myosin 
light chain kinases have been isolated from 
numerous mammalian tissues and their regulation 
studied [3-51. The best studied to date is the en- 
zyme from turkey gizzard which has been isolated 
as an Mr 130000 polypeptide [2,6]. During at- 
tempts to purify this enzyme we consistently 
observed two distinct forms of the kinase. This 
Abbreviations: ATPyS, adenosine 5’-o- 
(3-thiotriphosphate); CTP, cytidine 5 ‘-triphosphate; 
DTT, dithiothreitol; EGTA, ethylene glycol bis (8- 
aminoethyl ether)-N,N, N ‘, N ‘-tetraacetic acid; ITP, in- 
osine 5 ’ -triphosphate; MLCK, myosin light chain 
kinase; PAGE, polyacrylamide gel electrophoresis; SDS, 
sodium dodecyl sulfate 
paper describes these observations and the 
purification and partial characterization of a 
hitherto undescribed myosin light chain kinase of 
turkey gizzard. 
2. MATERIALS AND METHODS 
The following proteins were prepared as describ- 
ed: myosin [7], M, 130000 MLCK [6], 
tropomyosin [8], cu-actinin [9] and filamin [lo] 
from turkey gizzard, fibronectin [11,12] from 
bovine blood, calmodulin [6] from bovine testes 
and actin [13] from rabbit skeletal muscle. Vin- 
culin was prepared as in [14] and further purified 
through hydroxylapatite and Ultrogel 34. Casein, 
phosvitin, histone II A, histone III S, histone V S, 
protamine, phosphorylase b and phosphorylase 
kinase were purchased from Sigma Chemical Co. 
(St Louis MO). [T-~~P]ATP was obtained from 
New England Nuclear, ATPyS from Boehringer- 
Mannheim, and CTP and ITP from Sigma 
Chemical Co. 
Calmodulin was coupled to Sepharose 4B as in 
[ 151. Protein concentrations were determined by 
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the biuret method (161, by the dye-binding assay 
[17], or spectrophotometrically in the case of pure 
calmodulin and M, 130000 myosin light chain 
kinase: &‘i = 1.8 [18] and &$ = 11.4 [2], respec- 
tively. Polyacrylamide gradient slab gel elec- 
trophoresis in the presence of 0.1% SDS was per- 
formed at 30 mA [ 191. Coomassie blue-stained gels 
were scanned at 550 nm as in [20]. Urea-PAGE 
was done as in [21]. 
Myosin light chain kinase activity was assayed at 
25°C in the presence of 25 mM Tris-HCl (pH 
7.5), 0.1 mM CaCl2 (or 1 mM EGTA), 4 mM 
MgC12, 60 mM KCl, 15 pug calmodulin/ml, 0.5 mg 
myosin/ml and 0.75 mM [Y-~~P]ATP 
(2000-3000 cpm/nmol) as in [6]. 
from frozen turkey gizzards essentially as in [2] 
through the Sephacryl S-300 column, with the ex- 
ception that the ammonium sulfate fractionation 
was performed as follows: Solid ammonium 
sulfate was added to the Mg2+ extract supernatant 
to 60% saturation. Extraction buffer was then 
added to reduce the ammonium sulfate concentra- 
tion to 40% saturation. After centrifugation at 
15000 x g for 30 min, additional solid ammonium 
sulfate was added to the supernatant o a final 
60% saturation. The 40-60% pellet obtained by 
centrifugation at 15000 x g for 30 min was 
redissolved and dialyzed prior to gel filtration 
essentially as in [2]. The advantage of this ‘reverse’ 
ammonium sulfate procedure is that it maximizes 
removal of protease activity from the kinase. 
3. RESULTS AND DISCUSSION 
Myosin light chain kinase was partially purified 
The pooled kinase-containing fractions from the 
Sephacryl S-300 column were dialyzed vs 2 x 10 1 
of 15 mM Tris-HCl (pH 7.5), 1 mM EGTA, 
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Fig.1. DEAE-Sephacel ion-exchange chromatography. The dialyzed pool from Sephacryl S-300 was applied to a 
column (1.4 x 25 cm) of DEAE-Sephacel pre-equilibrated with buffer A. Bound proteins were eluted with a linear 
(O-O.6 M) NaCl gradient (-- -) generated from 300 ml each of buffer A and buffer A containing 0.6 M NaCI. 
Fractions (3 ml) were collected at 20 ml/h. Aliquots (10 ~1) of selected column fractions were assayed for myosin light 
chain kinase activity in the presence of 0.1 mM CaC12 (X---X) in a total reaction volume of 0.5 ml as in section 2. Assay 
mixtures were incubated at 25°C for 5 min. 
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1 mM DTT (Buffer A) and chromatographed on a 
column of DEAE-Sephacel (fig.1). Two peaks of 
myosin light chain kinase activity were eluted from 
the column suggesting the existence of two distinct 
forms of the enzyme. This possibility was cor- 
roborated by the finding that two peaks of myosin 
light chain kinase activity were also separated 
when the pooled Sephacryl S-300 fractions were 
chromatographed on columns of Affi-Gel blue or 
DEAE-Affi-Gel blue, Further purification of the 
peak II enzyme in fig.1 showed it to be the well- 
characterized M, 130000 enzyme [2,6]. The peak I 
enzyme was further purified by affinity 
chromatography on a column of calmodulin 
coupled to Sepharose 4B (fig.2). The kinase- 
containing fractions eluted with EGTA were com- 
posed of a high A4, doublet (fig.3). Gel scanning 
revealed this doublet to be > 95% pure. Den- 
sitometric scans of similar gels of 4 different kinase 
preparations yielded the following A: B ratios, 
1.23:1, 1.03:1, 1.26:1 and 1.24:1. The two 
polypeptides, A and B, could not be separated 
under non-denaturing conditions suggesting that 
the peak I kinase consists of two subunits, A and 
B. It is possible, however, that B may be derived 
from A by proteolysis. A and B were determined 
to have M, of 141000 and 136000, respectively, by 
SDS-polyacrylamide gradient gel electrophoresis 
[22]. A and B are clearly separated from the A4, 
130000 kinase by electrophoresis in the presence of 
1 I I I I 
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Fig.2. Calmodulin-Sepharose 4B affinity chromatography. Peak I from DEAE-Sephacel was dialyzed vs 2 x 10 1 of 
15 mM Tris-HCl (pH 7.5), 1 mM EGTA, 1 mM DTT. CaClz, MgClz and leupeptin were added to final concentrations 
of 1.5 mM (i.e., 0.5 mM excess over EGTA), 1 mM and 1 mg/l, respectively, and the sample loaded on a column 
(1 x 19 cm) of calmodulin coupled to Sepharose 4B pre-equilibrated with 15 mM Tris-HCl (pH 7.5), 0.5 mM CaC12, 
1 mM MgClz, 1 mM DTT, leupeptin (1 mg/l) (buffer B). Fractions (3.3 ml) were collected at 14.4 ml/h. After washing 
off excess protein with buffer B, non-specifically bound proteins were eluted by application of buffer B containing 
0.2 M NaCl (arrow 1). Finally, specifically bound proteins were eluted with 15 mM Tris-HCl (pH 7.5), 2 mM EGTA, 
1 mM MgClz, 1 mM DTT, 0.2 M NaCl (arrow 2). Selected fractions were assayed for myosin light chain kinase activity 
in the presence of 0.1 mM CaCl2 (X---X) or 1 mM EGTA (o---O) as in section 2. 
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Table 1 
Ca’+, calmodulin-dependence of peak I myosin light 
chain kinase 
Conditions Kinase activity 
(mol Pi incorp.1 
mol myosin) 
+ Ca2+ + calmodulin 1.44 
+ Ca’+ - calmodulin 0.35 
- Ca2+ + calmodulin 0.09 
- Ca2+ - calmodulin 0.09 
Peak I kinase purified through calmodulin-Sepharose 
4B was incubated for 3 min at 25% and 20pg/ml in 
25 mM Tris-HCl (pH 7.5), 4 mM MgC12, 60 mM KCl, 
0.5 mg myosin/ml, 0.75 mM [y-32P]ATP 
(2400 cpm/nmol), and either 0.1 mM CaClz ( + Ca’+) or 
1 mM EGTA (- Ca2+), in the presence and absence of 
15 pg calmodulin/ml, prior to quantitation of protein- 
bound 32P 
TOP 
J 
I kinase is Ca’+-dependent. The data in table 1 
substantiate this finding and demonstrate also the 
calmodulin dependence of this enzyme. The low 
level of phosphorylation observed in the presence 
of Ca2+ and absence of added calmodulin reflects 
a trace of contaminating calmodulin in the myosin 
preparation. 
Peak I kinase specifically phosphorylated the Mr 
20000 light chain of myosin as shown by 
SDS-PAGE and autoradiography and also 
urea-PAGE followed by gel slicing and quantita- 
tion of 32P in the gel slices (not shown). The site of 
phosphorylation in the it4, 20000 light chain 
(serine-19 [23]) catalyzed by M, 130000 MLCK is 
also the site phosphorylated by the peak I kinase 
(fig.4): if the two kinases phosphorylated ifferent 
sites on the M, 20000 light chain, one would expect 
an increase in phosphate incorporation ap- 
proaching 4 mol/mol myosin following addition 
of the i% 130000 kinase. This is clearly not the 
case. Furthermore, when the two kinases were add- 
ed in reverse order (i.e., M, 130000 then peak I) 
results identical to those in fig.4 were obtained. 
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Fig.3. Purity of peak I myosin light chain kinase. An 
aliquot (5 pg) of the EGTA eluate from 
calmodulin-Sepharose 4B was electrophoresed in a 
0.1% SDS, 7.5-20% polyacrylamide gradient gel. The 
Coomassie blue-stained gel was scanned at 550 nm. The 
inset shows a close-up of the scan in the region of the 
high M, doublet to demonstrate more clearly the two 
bands. 
SDS in either 7.5-12.5% or 5-10% 
polyacrylamide gradient gels. 
It is clear from fig.2 that the activity of the peak 
Fig.4. Sequential phosphorylation of myosin by peak I 
and peak II myosin light chain kinases. Purified peak I 
kinase (4.2,~g/ml) was incubated at 25°C in 25 mM 
Tris-HCl (pH 7.5), 0.1 mM CaC12, 4 mM MgC12, 
60 mM KCI, 15 pg calmodulin/ml, 0.5 mg myosin/ml 
and 0.75 mM [y-32P]ATP (2300 cpm/nmol) in 11 ml 
total reaction vol. Aliquots (0.5 ml) were withdrawn at 
the indicated times for quantitation of protein-bound 
“P. At 11 min (arrow l), additional purified peak I 
kinase was added to 4.2pg/ml final cont. to ensure 
maximal phosphorylation by this kinase. Then at 
22 min, purified M, 13OOGU kinase was added to 
4.2 pg/ml final cont. 
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As in the case of the M,l30000 kinase, the peak 
I enzyme appears to be specific for the M, 20000 
light chain of myosin. The following proteins were 
examined as potential substrates of the peak I 
kinase and none were phosphorylated: casein, 
phosphorylase b, phosphorylase kinase, prot- 
amine, tropomyosin, cu-actinin, vinculin, 
fibronectin, filamin, actin, histone II A, histone 
III S, histone V S, and protamine. Also, incuba- 
tion of the peak I kinase with a crude homogenate 
supernatant of turkey gizzard in the presence of 
[Y-~~P]ATP with and without Ca2+ and 
calmodulin, followed by SDS-PAGE and 
autoradiography, revealed no endogenous 
substrate of this kinase. Similar to earlier findings 
with the M, 130000 kinase, while the ATP analog, 
ATPyS, is used as a substrate by the peak I en- 
zyme, it will not use either CTP or ITP. 
The M, 130000 myosin light chain kinase (peak 
II enzyme) may be derived from the peak I enzyme 
by partial proteolysis or it may be a distinct form 
of the enzyme. If there are indeed two distinct 
forms, elucidation of the physiological significance 
will lead to a fuller understanding of the regulation 
of smooth muscle contraction. 
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